InvestorsHub Logo
Followers 88
Posts 1175
Boards Moderated 0
Alias Born 09/10/2017

Re: Poor Man - post# 367236

Monday, 04/05/2021 3:40:29 AM

Monday, April 05, 2021 3:40:29 AM

Post# of 708465
Poor Man, I’m not sure how you can determine what value Corning saw from the MicroDen system, or who terminated the supply agreement. Corning was responsible for handling sales of the device, but it was just another product they sold, and I doubt they had dedicated employees to support this. Further, once Northwest Bio bought Flaskworks, Corning wouldn’t have to do ANY sales. They would simply manufacture and supply the disposable plasticware for a soon-to-be commercial product. I agree that there probably wasn’t many MicroDen devices were sold prior to the acquisition, but then how many CAR-T manufacturing systems do you think were sold in 2016 before CAR-T was commercialized? And how many now? It may take a while to ramp production, but when it does, thousands of the single-use cartridges will be needed. I also think that once Northwest Bio commercializes a dendritic cell therapy, there will be many other copycats, just like CAR-T.

Shashi Murthy has given a number of presentations on automated cell manufacturing systems at Phacilitate, and other venues, some of which Linda Powers was also speaking. I’ve previously posted that I believe it was Linda Powers who approached Shashi Murthy to create the MicroDen product. It was Linda Powers and Northwest Biotherapeutics who needed a closed, automated system to commercialize a dendritic cell therapy. I’m not aware of any other company that is preparing to commercialize a dendritic cell therapy that would need such a system. I believe that Linda wants to be in control of the process and own the intellectual property.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News